Page last updated: 2024-08-21

fluorobenzenes and Thromboembolism, Venous

fluorobenzenes has been researched along with Thromboembolism, Venous in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	5 (62.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brummel-Ziedins, KE; Mann, KG; Undas, A	1
Li, L; Tian, JH; Yang, K; Zhang, P	1
Danielson, E; Fonseca, FA; Genest, J; Glynn, RJ; Gotto, AM; Kastelein, JJ; Koenig, W; Libby, P; Lorenzatti, AJ; MacFadyen, JG; Nordestgaard, BG; Ridker, PM; Shepherd, J; Willerson, JT	1
Bessias, N; Mikhailidis, DP; Paraskevas, KI; Perdikides, TP	1
Stewart, RA	1
Bartholomew, JR; Perez, A	1
Li, L; Sun, T; Tian, J; Yang, K; Zhang, P	1
Glynn, RJ; Libby, P; MacFadyen, JG; Pradhan, A; Ridker, PM	1

Reviews

3 review(s) available for fluorobenzenes and Thromboembolism, Venous

Article	Year
Anticoagulant effects of statins and their clinical implications. Thrombosis and haemostasis, 2014, Mar-03, Volume: 111, Issue:3 Topics: Animals; Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Endothelium, Vascular; Factor Va; Fluorobenzenes; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Animal; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Thrombin; Thrombomodulin; Thromboplastin; Venous Thromboembolism	2014
Statins for primary prevention of venous thromboembolism. The Cochrane database of systematic reviews, 2014, Dec-18, Issue:12 Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Stroke; Sulfonamides; Venous Thromboembolism; Venous Thrombosis	2014
Statins for primary prevention of venous thromboembolism. The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12 Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism	2011

Trials

3 trial(s) available for fluorobenzenes and Thromboembolism, Venous

Article	Year
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. The New England journal of medicine, 2009, Apr-30, Volume: 360, Issue:18 Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pulmonary Embolism; Pyrimidines; Risk; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism; Venous Thrombosis	2009
Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk. Future cardiology, 2009, Volume: 5, Issue:3 Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Confidence Intervals; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrimidines; Risk; Risk Assessment; Risk Factors; Risk Reduction Behavior; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism	2009
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (London, England), 2012, Aug-11, Volume: 380, Issue:9841 Topics: Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; United States; Venous Thromboembolism	2012

Other Studies

2 other study(ies) available for fluorobenzenes and Thromboembolism, Venous

Article	Year
Statins and venous thromboembolism: a novel effect of statins? Current medical research and opinion, 2009, Volume: 25, Issue:7 Topics: Adult; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism	2009
Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed. Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:3 Topics: Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Clinical Trials as Topic; Confidence Intervals; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism	2010

Article

Year

Statins and venous thromboembolism: a novel effect of statins?

Current medical research and opinion, 2009, Volume: 25, Issue:7

Topics: Adult; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Placebos; Pyrimidines; Randomized Controlled Trials as Topic; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism

2009

Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.

Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:3

Topics: Anticholesteremic Agents; C-Reactive Protein; Cholesterol, LDL; Clinical Trials as Topic; Confidence Intervals; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism

2010